These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11410486)

  • 1. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
    Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
    Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
    Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
    Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?
    Szukała K; Sowińska A; Wierzbicka M; Biczysko W; Szyfter W; Szyfter K
    Mutat Res; 2006 Aug; 600(1-2):67-76. PubMed ID: 16814812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
    Califano J; Westra WH; Meininger G; Corio R; Koch WM; Sidransky D
    Clin Cancer Res; 2000 Feb; 6(2):347-52. PubMed ID: 10690509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
    J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.
    Califano J; Leong PL; Koch WM; Eisenberger CF; Sidransky D; Westra WH
    Clin Cancer Res; 1999 Jul; 5(7):1862-7. PubMed ID: 10430093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary?
    Deganello A; Franchi A; Sardi I; Pignataro L; Leemans CR; Gallo O
    Cancer; 2010 Mar; 116(5):1291-7. PubMed ID: 20087960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
    Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
    Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelotype of head and neck squamous cell carcinoma.
    Nawroz H; van der Riet P; Hruban RH; Koch W; Ruppert JM; Sidransky D
    Cancer Res; 1994 Mar; 54(5):1152-5. PubMed ID: 8118797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
    Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
    Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
    Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An allelotype of squamous carcinoma of the head and neck using microsatellite markers.
    Ah-See KW; Cooke TG; Pickford IR; Soutar D; Balmain A
    Cancer Res; 1994 Apr; 54(7):1617-21. PubMed ID: 8137268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic discordance between primary tumours and metastases of head and neck cancer detected by microsatellite analysis.
    Götte K; Riedel F; Schäfer C; Coy JF; Hörmann K
    Oncol Rep; 2002; 9(4):829-34. PubMed ID: 12066217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
    Temam S; Casiraghi O; Lahaye JB; Bosq J; Zhou X; Julieron M; Mamelle G; Lee JJ; Mao L; Luboinski B; Benard J; Janot F
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4022-8. PubMed ID: 15217934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
    Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
    Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular support for field cancerization in the head and neck.
    Lydiatt WM; Anderson PE; Bazzana T; Casale M; Hughes CJ; Huvos AG; Lydiatt DD; Schantz SP
    Cancer; 1998 Apr; 82(7):1376-80. PubMed ID: 9529031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
    Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
    Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.